Now playing Next Healthcare France debates amendment on biomedicine substitution in pharmacies An amendment is being debated on whether pharmacies can substitute approved replacements for biological medicines, but patient organisations have raised concerns. 15/11/2023
Now playing Next Health news Fake Ozempic pens identified in European countries, EU regulators warn Ozempic is a diabetes medicine that has been in high demand. 19/10/2023
Now playing Next Health news EU regulators back authorisation of first RSV vaccine for infants RSV is a common respiratory virus that causes cold-like symptoms but can cause serious illness in children and older adults. 21/07/2023
Now playing Next world news European Medicines Agency COVID-19 warning The European Medicines Agency warns that the pandemic is not over and that it expects a new wave of COVID-19 infections to start within a week 26/10/2022
Now playing Next Netherlands European Medicines Agency approves Omicron booster vaccine The agency expects these vaccines to "help maintain optimal protection" against a continually evolving coronavirus 01/09/2022
Now playing Next Health news EU approves use of Bavarian Nordic vaccine against monkeypox The European Commission approved the use of the drug just days after the WHO called the spread of monkeypox a global health emergency. 25/07/2022
Now playing Next Health news Valneva’s inactivated COVID vaccine gets first approval in UK Valneva’s COVID-19 vaccine uses traditional technology that may appeal to people reluctant to take mRNA shots. 14/04/2022
Now playing Next Health news Too early to consider 4th COVID vaccine dose, say EU medical bodies While most people won't be considered for a fourth dose of COVID mRNA vaccine, those over 80 will be encouraged to get a second booster. 06/04/2022
Now playing Next Health news Moderna seeks emergency approval for COVID vaccine in kids under 6 Moderna’s COVID vaccine is around 44 per cent effective for children aged 6 months to 2 years old, early clinical trial results show. 23/03/2022
Now playing Next Health news WHO recommends Merck antiviral pill to treat high-risk COVID patients The World Health Organisation has recommended the use of Merck’s anti-COVID pill for the first time for those at high risk of hospitalisation. 03/03/2022
Now playing Next Health news EMA approves Pfizer's anti-COVID pill for use in the EU The antiviral drug Paxlovid reduced hospital admissions and deaths from COVID in at-risk people by up to 90 per cent, Pfizer said. 27/01/2022
Now playing Next Health news Antibiotic resistance killed 1.2 million people in 2019, study says Deaths from previously treatable infections such as pneumonia are rising as antibiotic resistance grows worldwide. 20/01/2022
Now playing Next Netherlands Novavax's COVID vaccine becomes fifth jab to be approved for use in EU Results from clinical trials released in June showed 90.4% efficacy against the disease, and 100% efficacy against severe to moderate cases. 20/12/2021
Now playing Next Health news Pfizer’s says its COVID pill is highly effective in high risk cases The pharmaceutical company says it intends to ask for authorisation for the pill from international regulators. 05/11/2021
Now playing Next world news EU medicines agency approves Moderna COVID-19 vaccine booster dose The European medicines regulator said data showed a third dose of Moderna's COVID-19 vaccine led to a rise in antibody levels. 25/10/2021
Now playing Next world news EU watchdog mulling authorisation of Merck's anti-COVID pill The European Medicines Agency has started reviewing Merck's COVID-19 antiviral treatment, the first pill that has been shown to treat the disease. 25/10/2021
Now playing Next Health news Pfizer’s COVID vaccine ‘91% effective’ in children aged 5-11 Young children were found to have strong protection from COVID-19 with Pfizer's COVID vaccine according to new data. 22/10/2021
Now playing Next Health news Denmark still offering kids Moderna jab, despite what it said earlier Danish authorities said a Wednesday announcement seeming to restrict the use of the Moderna jab was badly worded, and that the country continued to offer under-18s the vaccine. 08/10/2021
Now playing Next Health news Sweden and Denmark halt use of Moderna vaccine in younger people Noting it was an extremely rare side effect, the Swedish and Danish health authorities put Moderna use on hold due to the risks of heart inflammation. 07/10/2021
Now playing Next Health news COVID: EMA backs 3rd vaccine dose for people with weak immune systems The EMA has advised people with "severely weakened immune systems" to get a third dose of the Pfizer-BioNTech or Moderna COVID vaccines. 05/10/2021
ADVERTISEMENT
ADVERTISEMENT